Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

MSD withdraws European application of Keytruda combo in lung cancer

October 30, 2017 Sales and Marketing EMA, MSD, keytruda

MSD has been forced to withdraw its EU marketing application for Keytruda (pembrolizumab) in combination with pemetrexed and carboplatin as …
News
astrazeneca_sign_sky

AstraZeneca licenses genetic disease drug to Mereo Biopharma for $5 million, becomes shareholder

October 30, 2017 Sales and Marketing AstraZeneca, Mereo BioPharma, pharma

AstraZeneca has agreed to license AZD9668, its experimental drug for the treatment of alpha-1 antitrypsin deficiency, to Mereo Biopharma for …
News
novartis_window

Novartis to bolster oncology portfolio with $3.9 billion acquisition

October 30, 2017 Sales and Marketing Advanced Acclerator Applications, Lutathera, Novartis, pharma

Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce …
News
merckentranceweb

Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

October 30, 2017 Manufacturing and Production, Sales and Marketing Korea, MSD, Samsung BioLogics, pharma

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the …
News
pfizer-building-logo1web

Switching Crohn’s patients to biosimilar Inflectra from Remicade is safe and effective, Pfizer says

October 30, 2017 Research and Development, Sales and Marketing Crohn’s disease, Pfizer, Remicade, crohn's disease, inflectra, pharma

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …
News
online_survey_icon_or_logo

Collaboration in Biopharma

October 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague,
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …
News
shutterstock_138095450

Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl

October 27, 2017 Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids

John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …
News
celgene_exteriors-3

Celgene hikes price of Revlimid to mask poor Q3 results

October 27, 2017 Medical Communications, Sales and Marketing Celgene, Revlimid, biotech, drugs, pharma, pharmaceutical

Celgene posted its Q3 results and investors did not react well – shares plunged 16% immediately, after the biotech cut …
News
amber_hr_2

Is the NHS prepared for the upcoming winter season?

October 26, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Interview, NHS, pharma

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …
Feature
gsk_wall

GSK eyes healthcare expansion, hits targets due to new drugs

October 26, 2017 Sales and Marketing GSK, Merck KGaA, Pfizer, biotech, drugs, healthcare, pharma, pharmaceutical

During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …
News

Pfizer to begin auction of consumer health division next month

October 26, 2017 Sales and Marketing GSK, Pfizer, Proctor & Gamble, Sanofi, nestle

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …
News

Sanofi launches patent infringement lawsuit against Mylan over diabetes pen

October 25, 2017 Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …
News
lilly2_web

Lilly looks to leave behind animal health business

October 25, 2017 Research and Development, Sales and Marketing Elanco, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …
News

GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost

October 25, 2017 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026